![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GPR39 mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1315539 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GPR39 mRNA | CTD | PMID:22079256 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1315540 | 6480464 | Ethinyl Estradiol affects the expression of GPR39 mRNA | CTD | PMID:17555576 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPR39 mRNA | CTD | PMID:33387578 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:1315540 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of GPR39 gene | CTD | PMID:31683443 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of GPR39 mRNA | CTD | PMID:24780913 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of GPR39 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases expression | ISO | RGD:1315540 | 6480464 | Aflatoxin B1 results in decreased expression of GPR39 mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases methylation | ISO | RGD:1315539 | 6480464 | Aflatoxin B1 results in increased methylation of GPR39 intron | CTD | PMID:30157460 | arsane | affects methylation | ISO | RGD:1315539 | 6480464 | Arsenic affects the methylation of GPR39 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1315539 | 6480464 | Arsenic affects the methylation of GPR39 gene | CTD | PMID:25304211 | benzo[a]pyrene | affects methylation | ISO | RGD:1315539 | 6480464 | Benzo(a)pyrene affects the methylation of GPR39 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | RGD:1315539 | 6480464 | Benzo(a)pyrene results in decreased methylation of GPR39 exon | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:1315539 | 6480464 | 7 more ... | CTD | PMID:19150397 | benzo[a]pyrene diol epoxide I | affects expression | ISO | RGD:1315539 | 6480464 | 7 more ... | CTD | PMID:20382639 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GPR39 mRNA | CTD | PMID:25181051, PMID:34947998 | bisphenol A | increases methylation | ISO | RGD:1315539 | 6480464 | bisphenol A results in increased methylation of GPR39 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | RGD:1315539 | 6480464 | bisphenol A results in decreased expression of GPR39 mRNA | CTD | PMID:29275510 | bisphenol A | decreases methylation | ISO | RGD:1315540 | 6480464 | bisphenol A results in decreased methylation of GPR39 promoter | CTD | PMID:27312807 | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of GPR39 mRNA | CTD | PMID:32479839 | calcitriol | decreases expression | ISO | RGD:1315539 | 6480464 | Calcitriol results in decreased expression of GPR39 mRNA | CTD | PMID:16002434 | chromium(6+) | decreases expression | ISO | RGD:1315539 | 6480464 | chromium hexavalent ion results in decreased expression of GPR39 mRNA | CTD | PMID:30690063 | cisplatin | decreases expression | ISO | RGD:1315539 | 6480464 | Cisplatin results in decreased expression of GPR39 mRNA | CTD | PMID:21603599 | cisplatin | multiple interactions | ISO | RGD:1315539 | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of GPR39 mRNA | CTD | PMID:27392435 | dextran sulfate | multiple interactions | ISO | RGD:1315540 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR39 mRNA | CTD | PMID:29950665 | disodium selenite | decreases expression | ISO | RGD:1315539 | 6480464 | Sodium Selenite results in decreased expression of GPR39 mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | ISO | RGD:1315539 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of GPR39 mRNA | CTD | PMID:29391264 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of GPR39 gene | CTD | PMID:22079235 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of GPR39 mRNA | CTD | PMID:33387578 | mercury dibromide | increases expression | ISO | RGD:1315539 | 6480464 | mercuric bromide results in increased expression of GPR39 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | RGD:1315539 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR39 mRNA | CTD | PMID:27188386 | methylmercury chloride | increases expression | ISO | RGD:1315539 | 6480464 | methylmercuric chloride results in increased expression of GPR39 mRNA | CTD | PMID:28001369 | nickel atom | increases expression | ISO | RGD:1315539 | 6480464 | Nickel results in increased expression of GPR39 mRNA | CTD | PMID:25583101 | nickel sulfate | increases expression | ISO | RGD:1315539 | 6480464 | nickel sulfate results in increased expression of GPR39 mRNA | CTD | PMID:22714537 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GPR39 mRNA | CTD | PMID:33387578 | phenylmercury acetate | increases expression | ISO | RGD:1315539 | 6480464 | Phenylmercuric Acetate results in increased expression of GPR39 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1315539 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR39 mRNA | CTD | PMID:27188386 | potassium chromate | multiple interactions | ISO | RGD:1315539 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GPR39 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:1315539 | 6480464 | potassium chromate(VI) results in decreased expression of GPR39 mRNA | CTD | PMID:22079256, PMID:22714537 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of GPR39 mRNA | CTD | PMID:28374803 | rotenone | decreases expression | ISO | RGD:1315539 | 6480464 | Rotenone results in decreased expression of GPR39 mRNA | CTD | PMID:29955902 | SB 431542 | multiple interactions | ISO | RGD:1315539 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | RGD:1315539 | 6480464 | sodium arsenite results in increased expression of GPR39 mRNA | CTD | PMID:22714537 | sotorasib | multiple interactions | ISO | RGD:1315539 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GPR39 mRNA | CTD | PMID:36139627 | sunitinib | decreases expression | ISO | RGD:1315539 | 6480464 | Sunitinib results in decreased expression of GPR39 mRNA | CTD | PMID:31533062 | tetrachloromethane | affects expression | ISO | RGD:1315540 | 6480464 | Carbon Tetrachloride affects the expression of GPR39 mRNA | CTD | PMID:17484886 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of GPR39 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GPR39 mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of GPR39 mRNA | CTD | PMID:34492290 | titanium dioxide | multiple interactions | ISO | RGD:1315540 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR39 mRNA | CTD | PMID:29950665 | trametinib | multiple interactions | ISO | RGD:1315539 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GPR39 mRNA | CTD | PMID:36139627 | |